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Abstract
The tumor suppressor p53 has a crucial role in the DNA damage response. Here, we proposed an integrated model of the
p53 network and explored how the nuclear and mitochondrial p53 pathways are coordinated to determine cell fates after c-
irradiation in radiosensitive tissues. Using numerical simulations, we found that depending on the extent of DNA damage,
cells may survive, commit apoptosis after cell cycle arrest, or undergo apoptosis soon after irradiation. There exists a large
cell-to-cell variability in outcome because of stochasticity in the generation and repair of DNA damage as well as cellular
heterogeneity. At the cell population level, there occur two waves of apoptosis: a fast wave mediated by mitochondrial p53
within three hours postirradiation, and a slow wave mediated by nuclear p53 after eight hours postirradiation. Thus, we
propose a two-step mechanism for cell fate decision. The first step is to decide whether DNA damage is severe enough to
trigger apoptosis directly through the mitochondrial p53 pathway, while the second step is to determine whether the
damage is fixed after cell cycle arrest. Such a mechanism may represent an efficient and reliable control mode, avoiding
unnecessary death or greatly promoting the execution of apoptosis. It was also demonstrated that nuclear p53 can inhibit
the pro-apoptotic activity of mitochondrial p53 by transactivating p21, and Mdm2 can facilitate apoptosis by promoting the
mono-ubiquitination of p53. These results are either in good agreement with experimental observations or experimentally
testable. Our work suggests that both the transcription-independent and -dependent p53 activities are indispensable for a
reliable choice of cell fate and also provides clues to therapeutic manipulation of the p53 pathway in cancer treatment.
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Introduction
As a tumor suppressor, p53 lies at the hub of cellular signaling
networks that are activated by various stresses including DNA
damage, hypoxia and oncogene activation [1,2]. The p53-
mediated DNA damage response has been extensively studied.
p53 can induce different cellular outcomes such as cell cycle arrest,
senescence and apoptosis [3]. Especially, p53-mediated apoptosis
is critical for suppressing tumorigenesis, and the activities of
nuclear, cytoplasmic and mitochondrial p53 are all involved in
apoptosis induction.
Nuclear p53 functions as a transcription factor, regulating
expression of target genes. It can trigger apoptosis by transactivat-
ing pro-apoptotic genes such as Bax, Puma, Noxa and Bid and/or
by repressing the expression of anti-apoptotic genes including Bcl-
2, Bcl-xL and survivin [4,5]. These lead to mitochondrial outer
membrane permeabilization, cytochrome c (CytoC) release and
caspase activation, and apoptosis ensues. While the nuclear p53
pathway has been recognized as the main route to apoptosis, there
is now converging evidence that the transcription-independent
p53 activity can induce apoptosis directly [6–11]. In response to
death stimuli, a fraction of cellular p53 rapidly accumulates in the
cytosol or mitochondria, which leads to direct activation of Bax
and/or Bak and thus the initiation of apoptosis [12–14]. More
importantly, the pro-apoptotic activity of mitochondrial p53 can
come into action much faster than that of nuclear p53. It was
reported that within 30 min poststimulation, p53 accumulates in
mitochondria in radiosensitive organs (such as thymus and spleen),
triggering a rapid wave of apoptosis that precedes the induction of
pro-apoptotic p53 target genes [15]. Nevertheless, it still remains
elusive how the transcription-independent and -dependent activ-
ities of p53 are orchestrated to determine cell fates after DNA
damage.
The pro-apoptotic activity is a bright side of nuclear p53, by
which it fulfills a tremendous tumor-suppressing function. How-
ever, convincing evidence shows that p53 also has a dark side,
exhibiting powerful anti-apoptotic activity [16]. Besides the pro-
apoptotic genes, nuclear p53 also transcribes several anti-apoptotic
genes to counteract apoptosis. One of the main players involved is
the cyclin-dependent kinase inhibitor p21, which can repress
apoptosis in addition to its profound role in inhibiting prolifera-
tion. Multiple mechanisms were proposed for the anti-apoptotic
activity of p21 [17]. However, it remains to be established how the
anti-apoptotic activity of nuclear p53 and the pro-apoptotic
activity of extranuclear p53 are functionally correlated.
Although many mathematical models were developed to
explore the mechanism of p53-mediated cell fate decision [18–
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activity of p53, and few models took into account the mitochon-
drial p53 pathway. Especially, the coordination between the
activities of nuclear and mitochondrial p53 in the DNA damage
response needs to be further elucidated.
Motivated by the above considerations, we constructed a
model for the p53 network in response to DNA damage caused
by c-irradiation (cIR) and associated the network dynamics with
cellular outcomes in radiosensitive tissues. By numerical simula-
tions, we found that a reliable choice of cell fate between survival
and death engages both the transcription-independent and -
dependent activities of p53. We show that there appear three
kinds of cellular outcomes after DNA damage: survival, apoptosis
following cell cycle arrest, or immediate apoptosis. Our results
indicate that both the nuclear and mitochondrial p53 pathways
are important for cell fate decision and an emergence response
can be triggered to kill seriously damaged cells.
Materials and Methods
We seek to reveal the mechanism for the p53-mediated cellular
response to cIR in radiosensitive organs of normal mice [15]. The
schematic diagram of the model is depicted in Figure 1. The
subnetwork of the p53-Mdm2 loop is an extension of the model in
Ciliberto et al. [18] by incorporating the ubiquitination of
cytoplasmic p53, and the subnetwork of caspase-3 (Casp3)
activation is an extension of the model in Zhang et al. [20] by
integrating the activation of Bak by both mitochondrial p53 and
PUMA. Note that p53 exhibits the switch-like rather than
oscillatory behavior in the experiment by Erster et al. [15]. Thus,
the oscillatory dynamics of p53 were not considered here. The
irradiation dose is denoted by DIR.
Simulation of the Generation and Repair of DNA Damage
Upon cIR, double-strand breaks (DSBs) are typically induced,
and DNA repair proteins are quickly recruited to break sites [23].
For a population of cells exposed to the same irradiation dose of
DIR, the expected total numbers of DSBs are assumed to obey a
Poisson distribution with a mean of 35|DIR [19,21]. Taking into
account that radiation damage is more gradual and prolonged in
nature, the formation and repair of DSBs are simulated
simultaneously here. The production rate of DSBs is assumed to
be an exponential function of time, i.e., 35|DIR|k1|e{k1:t
with k1~ln2=T1=2 [24]. T1=2 represents the time it takes for half of
total DSBs to be generated. It is also assumed that there are 20
repair proteins per cell since they are much fewer than DSBs in
most cases [19,21]. The repair of DSBs can be simplified into a
stochastic three-state process: a reversible binding of repair
proteins and DSB into a DSB-protein complex (DSBC), and an
irreversible repair process from DSBC to fixed DNA [19,21]. The
total number of unfixed DSBs and DSBCs is denoted by NDSB.
Two parallel repair pathways are included: one with fast kinetics
corresponding to repair of simple DSBs, and the other with slow
kinetics corresponding to repair of complex DSBs [25]. A Monte
Carlo method [19,21] was used to mimic the repair process (see
Method S1 and Figure S1 for detail).
Model Construction and Assumptions
DSBs are specifically detected by the ataxia-telangiectasia
mutated (ATM) kinase. Upon DNA damage, ATM gets activated
through auto-phosphorylation [26] and can be maintained at a
relatively high level until DSBs are effectively fixed [21]. ATM
transmits stress signals downstream by phosphorylating the
residues in Chk2, Mdm2 and p53. Consequently, the degradation
of Mdm2 is enhanced, while p53 is stabilized and activated [27].
For simplicity, we did not explicitly include ATM in the model,
assuming that the ATM level can be considered constant.
Activated p53 induces expression of Mdm2, which in turn
targets p53 for degradation, thereby enclosing a negative
feedback loop. Three forms of Mdm2 are considered here,
namely Mdm2n (nuclear form), Mdm2c (unphosphorylated
cytoplasmic form), and Mdm2Pc (phosphorylated cytoplasmic
form). Once phosphorylated by AKT, cytoplasmic Mdm2 can
translocate to the nucleus [28]. The phosphorylation of Mdm2c
is indirectly suppressed by p53 because p53-induced PTEN
inhibits the activity of AKT via PIP3 [20,29]. The degradation
rate of Mdm2n is assumed to increase with NDSB in the
Michaelis-Menten form, as in Ref. [18].
As an E3 ubiquitin ligase for p53, Mdm2 induces its
ubiquitination in the nucleus and cytoplasm [30]. Both Mdm2c
and Mdm2Pc induce the ubiquitination of p53 with the same
efficiency [31]. p53 is sequentially catalyzed to mono- and poly-
ubiquitinated forms. Poly-ubiquitination, which requires a poly-
meric ubiquitin chain with at least four subunits per single lysine
residue, targets p53 for efficient proteasomal degradation, whereas
mono-ubiquitination, which conjugates with a ubiquitin monomer
at one or multiple sites, promotes the nuclear export [30] or
mitochondrial translocation of p53 [32,33]. In each compartment
(the nucleus or cytoplasm), two forms of ubiquitinated p53 are
considered, namely the mono-ubiquitinated (p53U) and poly-
ubiquitinated (p53UU) forms. The degradation rate of p53UU is
set to be much larger than that of non-ubiquitinated p53 and
p53U. The mono-ubiquitinated p53 in the nucleus (p53Un)i s
exported into the cytoplasm. The mono-ubiquitinated p53 in the
cytoplasm (p53Uc) further translocates to mitochondria and then
undergoes rapid deubiquitination by mitochondrial HAUSP,
which is stress induced [33]. Thus, mitochondrial p53 (p53m)
refers to the non-ubiquitinated form here.
Mono-ubiquitinated nuclear p53 can still tetramerize but
remain transcriptionally inactive [34], whereas non-ubiquitinated
nuclear p53 (p53n) can induce gene expression. Based on its
phosphorylation status, p53n is further divided into p53 arrester
and p53 killer [20,21]. p53 arrester gets phosphorylated at Ser15/
20, whereas p53 killer undergoes further phosphorylation at Ser46.
Functionally, p53 arrester transactivates p21 to promote cell cycle
arrest, whereas p53 killer induces PUMA to promote apoptosis.
Here, the conversion from p53 arrester to p53 killer is controlled
by the dual-specificity tyrosine-phosphorylation-regulated
(DYRK2) kinase. DYRK2 is cytoplasmic in resting cells but
translocates to the nucleus after DNA damage, where it
phosphorylates p53 at Ser46 [3,35]. The transcription rate of
each gene is characterized with the Hill function. Considering the
cooperativity of the tetrameric form of p53 as a transcription
factor, the Hill coefficient is set to 4 [19–21]. The production rate
of each protein is proportional to the corresponding mRNA level.
Taken together, eight forms of p53 are included in the model,
namely p53c (non-ubiquitinated cytoplasmic form), p53Uc,
p53UUc, p53n (that is divided into p53 arrester and p53 killer),
p53Un, p53UUn, and p53m.
Besides its principal function of inhibiting cell proliferation, p21
acts as an inhibitor of apoptosis. In our model, the anti-apoptotic
function of p21 is accomplished by indirectly suppressing E2F1
and thus Apaf1 [20], which is involved in the formation of
apoptosomes. Both mitochondrial p53 and PUMA can release Bak
from its complex with anti-apoptotic Bcl-2 family members (such
as Bcl-2, Bcl-xL and Mcl-1) and activate it [13,14]. Activated Bak
(Bak*) then leads to a loss in membrane potential of mitochondria
and the release of CytoC. Once released, CytoC binds to Apaf1
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heptamer. This large protein complex then binds and activates
Casp3. Here, persistent activation of Casp3 is considered as the
indicator of apoptosis. The total level of Bak is assumed to be
constant because it is constitutively located in the outer
mitochondrial membrane [13,14].
Two positive feedback loops are involved in the regulation of
Casp3 activation. One is the double-negative feedback loop
between p21 and Casp3: p21 indirectly inhibits Casp3 as
mentioned above, whereas Casp3 cleaves and inactivates p21
[36]. The other positive feedback loop is between CytoC and
Casp3: the release of CytoC leads to Casp3 activation, and Casp3
Figure 1. Schematic depiction of the model. Upon c-irradiation, double-strand breaks (DSBs) are generated. The degradation of Mdm2 is
enhanced, while p53 is stabilized and activated. p53 is sequentially catalyzed to mono- and poly-ubiquitinated forms (p53U and p53UU) by Mdm2.
Poly-ubiquitination of p53 induces its degradation by the proteasome, whereas mono-ubiquitination of p53 promotes its nuclear export and
mitochondrial translocation. Based on its phosphorylation status, active nuclear p53 is distinguished between two forms, namely p53 arrester and
p53 killer. They induce the expression of p21 and PUMA, respectively. DYRK2 translocates to the nucleus after DNA damage, where it promotes the
conversion from p53 arrester to p53 killer. p21 indirectly suppresses E2F1 and thus Apaf1. Both mitochondrial p53 (p53m) and PUMA can activate Bak.
Activated Bak induces the release of CytoC from mitochondria. Once released, CytoC binds to Apaf1 and promotes the assembly of the apoptosome,
activating Casp3. Activated Casp3 cleaves p21 and the inhibitors of Bak. The transcription and translation of genes are denoted by dashed lines. State
transition is represented by arrow-headed solid lines, and the promotion and inhibition of state transition are separately denoted by triangle-headed
and bar-headed lines. Other processes are depicted by arrow-headed double lines. Different colors are used to mark distinct p53 pathways.
doi:10.1371/journal.pone.0038164.g001
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PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e38164Figure 2. Overview of the responses of the p53 network to c-irradiation with different doses. Shown are time courses of the number
of DSBs, the levels of non-ubiquitinated nuclear p53, p21, PUMA, mitochondrial p53, and Casp3 (from top to bottom) at DIR~1:0 (A), 5.0 (B) or 10.0
Gy (C). The cell fate is determined by the activities of nuclear and mitochondrial p53. Depending on the extent of DNA damage, the cell may survive
(A), undergo apoptosis after cell cycle arrest (B), or commit apoptosis soon after stress (C).
doi:10.1371/journal.pone.0038164.g002
Figure 3. Different cellular outcomes after DNA damage. Displayed are time courses of the levels of p21 (A), PUMA (B), p53m (C), and Casp3
(D) as a function of time and DIR. The protein levels are normalized to their respective peak values (see the color scale bar on the right). There exist
three cellular outcomes: survival (DIRv1:72 Gy), apoptosis following cell cycle (1:72ƒDIRv7:6 Gy), or immediate apoptosis (DIR§7:6 Gy).
doi:10.1371/journal.pone.0038164.g003
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CytoC release [37]. Interlinking the two loops constitutes a
bistable apoptotic switch, which underlies a reliable cell fate
decision.
Model Simulation and Bifurcation Analysis
The dynamics of proteins and mRNA transcripts are charac-
terized by ordinary differential equations, which are presented in
Method S2. The definition of each variable and a set of standard
parameter values are listed in Tables S1 and S2, respectively. The
differential equations were numerically solved by using a fourth-
order Runge-Kutta algorithm with a time step of 0.01 min. The
initial concentration of each species was set to its stable steady-
state value in the absence of DNA damage (i.e.,NDSB~0), which is
also listed in Table S1. The units of time and irradiation dose are
minutes and Gray (Gy), respectively, while the units of other
parameters ensure that the concentrations of proteins are
dimensionless. The bifurcation diagrams were plotted by using
Oscill8.
Results
Cellular Outcomes After DNA Damage
We first explored the cellular outcome following cIR. Figure 2
displays the network dynamics under different irradiation condi-
tions. Upon irradiation, DSBs are quickly generated and repair
proteins are recruited to break sites. At first NDSB increases with
time because the production rate of DSBs is larger than the repair
rate. After a peak, NDSB shows a decaying process with
discontinuous jumps, which are due to the assumption that the
step from DSBC to fixed DSB is irreversible. At DIR~1 Gy, the
p53n level undergoes a single low-amplitude pulse, and p53
arrester predominates over p53 killer (Figure 2A). Note that p53
arrester and p53 killer transactivate p21 and PUMA, respectively.
Thus, the p21 level also exhibits a single pulse with a delay,
whereas PUMA and p53m remain at basal levels. Consequently,
Casp3 is kept inactive. In this case, the cell cycle is first arrested to
allow time for DNA repair, and the cell recovers to normal
proliferation after the damage is fixed.
At DIR~5 Gy, the concentration of p53n first rises fast to a
relatively high level and then decreases progressively, while p53
arrester and p53 killer become dominant sequentially (Figure 2B).
Thus, the p21 level first exhibits a high-amplitude pulse, while the
PUMA level increases gradually. Consequently, cell cycle arrest is
first induced by p21 to facilitate DNA repair. When the damage is
beyond repair, enough PUMA accumulates to activate Bak.
Subsequently, the release of CytoC and activation of Casp3 lead to
the initiation of apoptosis around 8.3 h postirradiation. In this
case, the p53m level does not change markedly during the whole
response. It is worth noting that thymocytes are among the most
radiosensitive cells in mammals, with a surprising speed of
apoptosis induced by cIR. It was reported that exposing cultured
thymocytes to 5 Gy of cIR brings about 50% of death 8 h
postirradiation [38,39]. Therefore, the timing of apoptosis
induction here is in agreement with in vitro findings.
Figure 4. Biphasic-response patterns in apoptosis induction. The time point of Casp3 activation, TApop, is used as a measure of timing of
apoptosis. (A) Displayed are the curves of TApop versus DIR for different parameter sets where each parameter value is increased or decreased by 15%
with respect to its standard value. In the inset is shown the TApop curve for the standard parameter set. The biphasic-response pattern is robust to
variations in parameter values. (B) Shown are the histograms of TApop among a population of 2000 cells at DIR~3:0, 5:0, or 7:0 Gy (from left to right).
For each cell, all parameter values are randomly chosen from 85% to 115% of their standard values, and the expected total number of DSBs obeys a
Poisson distribution. The time bin is 20 min. (C) Shown is the temporal evolution of the percentage of apoptotic cells at different irradiation does by
simulation (lines) or quantified experimental dada (circles) from Figure 4B in Ref. [15]. (D) Displayed is the percentage of apoptotic cells during the
fast or slow wave as a function of irradiation dose.
doi:10.1371/journal.pone.0038164.g004
A Two-Step Mechanism for Cell Fate Decision
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e38164At DIR~10 Gy, the concentration of p53n remains at a
relatively high level after a transient response (Figure 2C).
However, the p21 level undergoes only a short pulse with lower
amplitude, whereas the p53m level rises remarkably soon after
cIR. Thus, there is no cell cycle arrest, and Bak is directly
activated by mitochondrial p53. In this case, the cell commits
apoptosis around 2.5 h postirradiation. That is, apoptosis is
induced very fast at high damage levels. This is consistent with the
experimental finding that a fast wave of apoptosis is triggered 2 h
after 10-Gy irradiation [15]. In our simulations, Casp3 activation
is all switch-like. Taken together, there appear three kinds of
cellular outcomes after cIR: survival, apoptosis following cell cycle
arrest, or immediate apoptosis.
To investigate the cell fate decision systematically, we plotted
the levels of p21, PUMA, p53m and Casp3 as a function of time
and DIR in Figure 3. To better illustrate the underlying
mechanism, time courses are divided into two phases by one
horizontal line (at 400 min), and the irradiation dose is designated
as a low, medium or high level on three intervals separated by two
vertical lines (at 1.72 and 7.6 Gy), respectively. In this way, the
phase space is divided into six regions.
For DIRv1:72 Gy, only the p21 level is significantly larger than
zero in the early phase, whereas other proteins remain at basal
levels. This indicates that p53 only induces p21 to arrest the cell
cycle and the cell survives minor DNA damage. For
1:72ƒDIRv7:6 Gy, the p21 level is around its peak values over
the time interval from 200 to 400 min and keeps lower in the later
phase, whereas the PUMA level rises evidently during the second
phase, especially at higher irradiation doses. p53m remains at a
relatively low level during the whole response. Thus, it is PUMA
that most promotes the activation of Bak and Casp3. Conse-
quently, nuclear p53-induced apoptosis occurs only in the second
phase. For DIR§7:6 Gy, p53 quickly accumulates in mitochon-
dria, and Bak is activated directly by p53m. Note that the level of
p21 only changes transiently because it is cleaved by Casp3. Thus,
no cell cycle arrest is evoked, and apoptosis is executed rapidly.
The induction of a fast apoptotic response has important
implications for maintaining the integrity of the genome.
Two Waves of Apoptosis
The above results indicate that apoptosis is induced either
after cell cycle arrest or soon after irradiation, depending on the
stress level. In the following, we use the time point of Casp3
activation, TApop, as a measure to quantitatively characterize
the timing of apoptosis. For the standard parameter set, TApop
is well defined only when DIR§D1~1:72 Gy (i.e., D1
represents the minimal irradiation dose capable of inducing
apoptosis; see the inset of Figure 4A). This is in agreement with
the experimental observation that a significant expression of
p53-targeted pro-apoptotic genes occurs in thymus and spleen
when DIR§1 Gy [40]. With DIR increasing, TApop first falls
fast from 934 min to 520 min and then decreases slowly until it
drops sharply to be around 150 min at D2~7:6 Gy. In fact, D1
and D2 correspond to two critical points where the negative
derivative of TApop with respect to DIR takes a local maximum
(see Figure S2). The values of TApop at D1 and D2 are
represented by T1 and T2, respectively. Notably, the value of
TApop is a good manifestation of whether apoptosis is triggered
quickly by mitochondrial p53 without cell cycle arrest or by
nuclear p53 after cell cycle arrest.
An issue naturally arises concerning whether the above results
are robust to parameter variation. To address this issue, each
parameter is increased or decreased by 15% with respect to its
standard value. Figure 4A displays TApop versus DIR for different
parameter sets. In all cases, the curves exhibit a similar trend; but
D2 varies over a wide range, while D1 changes slightly. The
relative changes in D1, T1, D2 and T2 are quantified in Figure S3.
Compared to the case with the standard parameter set, D1
changes by less than 15% for all cases, and T1 varies by 33% at
most. However, D2 is more sensitive to some parameters, with its
relative change being up to 100%, while T2 varies by 38% at most.
Nevertheless, both the fast and slow apoptotic responses exist in
each case.
On the other hand, it is of interest to probe the distribution
of TApop among a population of 2000 cells. As mentioned
above, the expected total number of DSBs for each cell is
generated from a Poisson distribution. Given cellular heteroge-
neity, each parameter value for every cell is randomly chosen
from 85% to 115% of its standard value. Thus, the cellular
responses exhibit a large variability. Notably, the histograms are
all bimodal for different DIR: TApop is either narrowly centered
around 150 min or widely distributed around 500 min
(Figure 4B). Therefore, at the population level, cells exhibit
Figure 5. The fast wave of apoptosis determined by the
competition between mitochondrial p53 and p53 arrester. (A)
Displayed are the bifurcation diagrams of the Caps3 level as a function
of p53m level for different levels of p53 arrester. The solid and dashed
lines represent stable and unstable steady states, respectively. The line
with arrow indicates the ascending order of p53 arrest. (B) Shown are
the bifurcation diagrams of the Caps3 level as a function of the
concentration of p53 arrester for different levels of p53m. The same
convention as in panel A. (C) Displayed is the two-parameter bifurcation
diagram of the levels of p53m and p53 arrester. The plane is divided into
two regions by the curve composed of the saddle-node bifurcation
points in panels A and B.
doi:10.1371/journal.pone.0038164.g005
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Some cells undergo apoptosis soon after irradiation, while others
may commit apoptosis at a much later time. Clearly, the first
rapid wave is transcription-independent, whereas the second
slow wave is transcription-dependent.
We also display how the percentage of apoptotic cells evolves
temporally under different irradiation conditions in Figure 4C.
There exist two time intervals where the percentage rises
remarkably, corresponding to the fast and slow waves of apoptosis,
respectively. It is worthy to note that our data for DIR~5 Gy are
in good agreement with the experimental data [15]. Moreover, the
percentage of apoptotic cells during the fast wave rises with
increasing DIR, while that during the slow wave first rises and then
falls with DIR (Figure 4D). For DIRv10 Gy, the nuclear p53-
mediated apoptosis predominates over the mitochondrial p53-
mediated apoptosis.
Whether apoptosis is induced quickly or not depends largely
on the competition between p53 arrester and mitochondrial p53
(cf. Figure 2C). Since it is difficult to directly analyze their
dynamic interactions, we can investigate the dependence of
steady-state Casp3 levels on p53 arrester and p53m, which is
obtained by setting the right-hand sides of all equations in
Method S2 to zero, with the levels of p53m and p53 arrester
being free parameters. Figure 5A shows the bifurcation
diagrams of the Casp3 level as a function of p53m level for
different levels of p53 arrester. The Casp3 level can switch from
the lower to the upper state when the p53m level crosses the
saddle-node bifurcation point. Once Casp3 is settled into the
upper state, it stays there independently of p53m. This is
responsible for the irreversible induction of apoptosis. The
threshold for switching on Casp3 increases with the level of p53
arrester. That is, when the level of p53 arrester becomes larger,
more accumulation of p53m is needed to turn on the Casp3
switch. On the other hand, Casp3 is switched on only with low
levels of p53 arrester, and improving p53m levels contributes to
the switching (Figure 5B).
In the parameter space spanned by the levels of p53m and p53
arrester, two regions are separated by the curve composed of the
above bifurcation points (Figure 5C). The top left corresponds to
Casp3 activation, while the other corresponds to Casp3 inactiva-
tion. This indeed indicates that an amount of mitochondrial p53
can lead to Casp3 activation when the level of p53 arrester is
controlled within an appropriate range. Therefore, whether fast
apoptosis can be induced rests on whether mitochondrial p53
predominates over p53 arrester.
Coordination of Nuclear and Mitochondrial p53 Activities
Our results suggest that both the transcription-dependent and -
independent activities of p53 are indispensable for making a
reliable cell-fate decision. To see this clearly, we constructed two
variant models: the p53n-only model where the pro-apoptotic
function of mitochondrial p53 is disabled (i.e., kbak1~0), and the
p53m-only model where the transcriptional activity of nuclear
p53 is disrupted (i.e., kp21~0, kpuma~0 and kmdm2~0). Such
assumptions are based on the reports that the pro-apoptotic
activity of mitochondrial p53 can be inhibited by Pifithrin-m [41]
and the role of nuclear p53 as a transcription factor can be
blocked by Pifithrin-a [42].
Figure 6. Coordination of the nuclear and mitochondrial p53 activities in apoptosis induction. (A) Shown are the TApop curves for three
models: the standard model (solid), the p53n-only model (dashed), and the p53m-only model (dotted). The pro-apoptotic function of mitochondrial
p53 is disabled in the p53n-only model, whereas the transcription of genes by nuclear p53 is disrupted in the p53m-only model. (B-D) The
contributions of different p53 activities to apoptosis induction. We changed the p53-dependent transcription rate of p21 (B), the p53-dependent
transcription rate of PUMA (C), and the translocation rate of p53m (D), respectively. Displayed are the TApop curves for different cases.
doi:10.1371/journal.pone.0038164.g006
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Casp3 activation, we plotted TApop versus DIR for three models
(with the standard parameter set) in Figure 6A. In the p53m-only
model, TApop drops from 390 min at DIR~2 Gy to a minimum of
less than 140 min. That is, when p21, PUMA and Mdm2 are
expressed only at basal levels, apoptosis always ensues soon after
stress. It is noted that although p53-dependent expression of
Mdm2 is inhibited, its basal expression generates low level of
Mdm2, which promotes the mono-ubiquitination and mitochon-
drial translocation of p53 (see Figure S4). Moreover, because the
inhibition of apoptosis by p21 is released, it is easier to trigger the
rapid apoptosis by mitochondrial p53. Furthermore, decreasing
the basal transcription rate of Mdm2 may enhance p53m-induced
apoptosis (see the red lines in Figure S4), and this point will be
discussed later. These results are consistent with the experimental
observations that disrupting the transcriptional activity of p53
greatly enhances rather than inhibits apoptosis induction [43–45].
This also suggests that combining anticancer drugs (like Nutlin-3,
which can upregulate p53 levels) with inhibitors of nuclear p53
(like Pifithrin-a) may be a promising way to improve the therapy
efficacy.
In the p53n-only model, however, TApop drops from 690 min at
DIR~2 Gy to 510 min at DIR~10 Gy. Thus, apoptosis is always
evoked slowly by nuclear p53 alone, even at high damage levels.
That is, blocking the extra-nuclear activity of p53 greatly delays
the initiation of apoptosis. Therefore, when the function of nuclear
p53 is interrupted, inappropriate cell death may be evoked; when
the function of mitochondrial p53 is disrupted, seriously damaged
cells cannot be destroyed timely. By contrast, the coordination of
both p53 activities can ensure a balance between cell survival and
death.
We further explored the influence of different p53 activities on
apoptosis induction. As mentioned above, nuclear p53 also has an
anti-apoptotic role via transcribing p21. To see this clearly, we
changed the p53-dependent transcription rate of p21, kp21, and
plotted the TApop curves in Figure 6B. When kp21 is doubled or
halved, TApop decreases with increasing DIR along the upper and
the lower branch, respectively. That is, the biphasic behavior
disappears. When p21 is transcribed faster, it takes a longer time to
induce apoptosis because p21 exerts a stronger suppression of
E2F1 activity. By contrast, when p21 is transcribed more slowly, it
takes less time to trigger apoptosis. Therefore, upregulating p21
expression tends to repress the induction of apoptosis.
On the other hand, doubling or halving the p53-dependent
transcription rate of PUMA (kpuma) has a much smaller effect on
the TApop curve (Figure 6C). When kpuma is increased from 0 to
two-fold its default value, D1 dwindles gradually from 3.4 to 1.5
Gy, but D2 varies slightly (Figure S5). Thus, the pro-apoptotic
activity of nuclear p53 regulates the slow wave of apoptosis but has
little effect on the nature of the biphasic response.
As shown above, the fast wave of apoptosis is triggered by
mitochondrial p53. Enhancing the translocation rate of p53m can
always facilitate the induction of apoptosis because Casp3 is
activated more quickly, escaping the repression of p21 (Figure 6D).
By contrast, weakening the translocation rate of p53m may delay
or abolish the fast wave of apoptosis. Thus, the activity of
mitochondrial p53 should be sufficiently strong so as to quickly
remove severely damaged cells. Taken together, both the nuclear
Figure 7. Different levels of Mdm2 have distinct effects on apoptosis induction. (A) Shown are the steady-state levels of p53n (solid) and
p53m (dashed) versus the Mdm2c level. (B) Displayed are the TApop curves. The translation rate of Mdm2, kMdm2, is 0.3- or 2-fold its standard value. (C)
Shown is the minimal irradiation dose required for apoptosis induction, D1, versus the ratio of the value of kMdm2 to its standard value. (D) The timing
of apoptosis at DIR~6 Gy versus the ratio of the value of kMdm2 to its standard value.
doi:10.1371/journal.pone.0038164.g007
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DNA damage response.
Two Faces of Mdm2: Inhibiting or Promoting Apoptosis
Induction
It is widely accepted that Mdm2 is an oncoprotein because it is
the major E3 ubiquitin ligase for p53. It is known that higher levels
of Mdm2 promote poly-ubiquitination of p53, while lower levels of
Mdm2 promote its mono-ubiquitination [30]. Mono-ubiquitinated
nuclear p53 can be exported to the cytoplasm and further
translocate to mitochondria upon stress. Thus, it is necessary to
investigate the influence of Mdm2 on the mitochondrial p53
pathway.
We first analyzed the dependence of the steady-state levels of
p53n and p53m on Mdm2c. The p53m level first rises and then
falls with increasing the Mdm2c level, whereas the p53n level
drops monotonically (Figure 7A). This is consistent with the
experimental observation of how the ubiquitination of p53
depends on Mdm2 [30]. Thus, there exists some possibility that
mitochondrial p53-mediated apoptosis can be facilitated by
improving Mdm2 levels over some range. That is, Mdm2 may
have a tumor-suppressing function via promoting the mono-
ubiquitination of p53. This is in contrast with the classical view
that Mdm2 is only an oncoprotein.
To address this possibility, we compared the TApop curves
between the cases with different translation rates of Mdm2 (kMdm2)
in Figure 7B. Clearly, when kMdm2 is 0.3-fold its standard value,
the fast wave of apoptosis disappears. Moreover, D1 rises
evidently, and it takes more time to trigger apoptosis. That is,
downregulating the expression of Mdm2 tends to inhibit apoptosis.
By contrast, when kMdm2 is two-fold its standard value, it takes
much less time to induce apoptosis but D1 becomes larger. Thus,
upregulating the expression of Mdm2 has a more complicated
effect on apoptosis induction; whether Mdm2 promotes or inhibits
apoptosis also depends on the extent of DNA damage, which
affects the degradation rate of Mdm2.
Furthermore, we plotted the minimal irradiation dose required
for apoptosis induction versus the ratio of the value of kMdm2 to its
standard value in Figure 7C. D1 first decreases and then rises with
increasing the ratio. Moreover, the time taken to initiate apoptosis
at DIR~6 Gy also first decreases and then rises with increasing the
ratio (Figure 7D). Thus, Mdm2 with appropriate levels may act as
a tumor suppressor. That is, Mdm2 has two faces; under certain
conditions, it can promote apoptosis by reducing the minimal
irradiation dose for apoptosis induction and/or speeding up
apoptosis initiation. Therefore, changing Mdm2 levels may switch
the role of Mdm2 between a tumor suppressor and an
oncoprotein. Accordingly, enhancing the pro-apoptotic activity
of mono-ubiquitinated p53 by targeting the p53-Mdm2 interac-
tion could be a potential therapeutic strategy in cancer treatment.
Discussion
In the present work, we developed a model of the p53 signaling
network in radiosensitive tissues to clarify how the cell fate decision
is governed by the nuclear and mitochondrial p53 pathways. We
found that depending on the extent of DNA damage, there exist
three kinds of cellular outcomes: 1) the cell survives, 2) the cell
commits apoptosis after cell cycle arrest, or 3) the cell undergoes
apoptosis soon after irradiation. At the population level, apoptosis
appears in two waves: the fast wave mediated by the mitochondrial
p53 pathway and the slow wave by the nuclear p53 pathway.
Therefore, we propose a two-step mechanism for cell fate decision
(Figure 8). The first step is to decide whether DNA damage is
severe enough to activate Casp3 directly through the mitochon-
drial p53 pathway. If yes, the apoptotic program is initiated, and
those cells are quickly eliminated with little time for DNA repair.
Otherwise, nuclear p53 transcribes p21, which induces cell cycle
arrest to allow DNA repair. The second step then determines
whether the repair is beyond repair. If yes, nuclear p53 induces
expression of pro-apoptotic genes, and apoptosis ensues; other-
wise, the cell survives.
Such a two-step mechanism may represent an optimal control
mode of the DNA damage response in radiosensitive tissues. Most
previous models assumed that cells always first arrest the cell cycle
to fix DNA damage no matter how severe it is [20,21]. This seems
not so favorable for three reasons. First, it is a waste of energy to
try to repair seriously damaged cells because they are destined for
death. Second, it is dangerous to repair severe DNA damage since
this could lead to genomic instability. Third, an emergency-
response mechanism is needed to eliminate seriously damaged
cells timely. By contrast, this two-step mechanism provides an
efficient and reliable control.
We have emphasized that the fast apoptosis is induced by the
mitochondrial p53 pathway. In fact, cytoplasmic p53 also has a
pro-apoptotic function when it is released from sequestration by
Bcl-2 or Bcl-xL, which is promoted by PUMA. Nevertheless,
PUMA expression is controlled by nuclear p53 [46,47]. Thus, this
endogenous pro-apoptotic function of cytoplasmic p53 still
depends on nuclear p53. That is, the cytoplasmic p53 pathway
cannot be qualified for triggering an emergency response, which
instead engages the mitochondrial p53 pathway.
Figure 8. Two-step mechanism for cell fate decision. The first
step is to decide whether DNA damage is severe enough to activate
Casp3 through the mitochondrial p53 pathway. If yes, the apoptotic
program is initiated without cell cycle arrest. Otherwise, nuclear p53
transcribes p21, which induces cell cycle arrest to allow DNA repair.
Then comes the second step, determining whether the repair is
completed. If yes, the cell survives; otherwise, p53 induces expression of
pro-apoptotic genes, and apoptosis ensues.
doi:10.1371/journal.pone.0038164.g008
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induction. Rather than simply repress apoptosis, Mdm2 with
moderate levels can promote apoptosis by facilitating or/and
speeding up apoptosis induction. Indeed, converging evidence
supports the remarkable possibility that Mdm2 has a tumor-
suppressing function within the appropriate context [48]. For
example, Mdm2 can suppress cell proliferation [49,50] or lead to
instability of mutant p53 in tumor [51]. Here, we found that
Mdm2 can promote apoptosis via mono-ubiquitination of p53.
This may be exploited to develop Mdm2-based cancer therapy.
The p53 dynamics in the DNA damage response are actually
cell-, tissue- and stress-specific. For example, oscillatory behaviors
of p53 have been reported both experimentally and theoretically
[19,21,52–55]. Positive and negative feedback loops have been
identified underlying p53 oscillations [22]. However, there is no
evidence supporting oscillatory p53 behavior in the experiment by
Erster et al. [15]. Thus, the oscillatory dynamics of p53 were not
considered in our model. But it would be interesting to check how
the coordination of nuclear and mitochondrial p53 activities is
affected by their response modes.
Our results suggest that a reliable cell fate decision involves the
coordination between the nuclear and mitochondrial p53 path-
ways, which may be exploited in cancer treatment. The cell cycle
arrest and slow wave of apoptosis can be induced by nuclear p53,
whereas mitochondrial p53 can trigger an emergency response at
high damage levels. Disrupting cell cycle arrest can greatly
enhance apoptosis induction. Thus, a possible strategy for cancer
therapy is to combine anticancer drugs with inhibitors of nuclear
p53. This could lower the dosage of drugs and shorten the
medication time. Therefore, manipulating both the nuclear and
mitochondrial p53 pathways may be a promising way to improve
the therapy efficacy.
Supporting Information
Figure S1 The two-lesion kinetic model of DNA repair.
Two parallel repair pathways are considered: one with fast kinetics
corresponding to repair of simple DSBs, and the other with slow
kinetics corresponding to repair of complex DSBs. For both
pathways, the repair of DNA damage is simplified into a three-
state process: a reversible binding of repair proteins and DSB (‘D’)
into DSBC (‘C’), followed by an irreversible repair process from
DSBC to fixed DNA (‘F’). Subscripts ‘1’ and ‘2’ are used to
distinguish fast kinetics from slow kinetics.
(TIFF)
Figure S2 Definitions of the minimal irradiation dose
capable of inducing apoptosis (D1) and that capable of
inducing fast apoptosis (D2). Shown is the negative derivative
of TApop with respect to DIR, which is defined as
{
TApop (DIRzDDIR){TApop (DIR)
DDIR
. The derivative takes a
local maximum at D1 and D2.
(TIFF)
Figure S3 Parameter sensitivity analysis of TApop. Here,
each parameter is increased (pentagon) or decreased (circle) by
15% with respect to its standard value. Compared to the case with
the standard parameter set, the relative changes in D1,T1,D2 and
T2 are separately quantified in panels A–D.
(TIFF)
Figure S4 Temporal evolution of protein levels in the
p53m-only model at DIR~5 Gy. Shown are the dynamics of
the levels of Mdm2n (A), p53Uc (B), p53m (C) and Casp3 (D) for
different basal levels of Mdm2.
(TIFF)
Figure S5 The dependence of D1 and D2 on the p53-
dependent transcription rate of puma, kpuma. D1 and D2
versus the ratio of the value of kpuma to its standard value
are shown in A and B, respectively.
(TIFF)
Method S1 Simulation method for the repair of DNA
damage.
(PDF)
Method S2 Ordinary differential equations for the
model.
(PDF)
Table S1 Description and initial values of the model
variables.
(PDF)
Table S2 Description and values of the model param-
eters.
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